Ligand Reports Second Quarter 2018 Financial Results
Go back to Ligand Reports Second Quarter 2018 Financial Results| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 288.55 -0.2 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $288.75 | 52 Week High | $139.79 | |||
| Open | $290.38 | 52 Week Low | $82.07 | |||
| Day High | $290.38 | P/E | 671.05 | |||
| Day Low | $288.54 | EPS | $0.43 | |||
| Volume | 5,337 | |||||

